Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology

Inhibition of soluble epoxide hydrolase alleviates insulin

Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro

Cardiomyocyte-specific disruption of soluble epoxide hydrolase

Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor

Deletion of soluble epoxide hydrolase suppressed chronic kidney

Optimization of Amide-Based Inhibitors of Soluble Epoxide

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects

A novel soluble epoxide hydrolase vaccine protects murine cardiac

Cardiomyocyte-specific disruption of soluble epoxide hydrolase

Therapeutic and Prognostic Significance of Arachidonic Acid in

Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic

Soluble epoxide hydrolase inhibition and gene deletion are

Nonsense mediated decay factor UPF3B is associated with cMyBP-C